Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease portal vein thrombosis
Symptom C0019204|hepatocellular carcinoma
Sentences 23
PubMedID- 23914640 Conclusion: colour doppler sonognaphy is an effective, non-invasive method for evaluating the presence of portal vein thrombosis associated with hepatocellular carcinoma.
PubMedID- 22689916 It is a safe and effective treatment prolonging the survival of hepatocellular carcinoma patients with portal vein thrombosis.
PubMedID- 23000237 Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression.
PubMedID- 24740759 Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis.
PubMedID- 21796552 We aimed to evaluate the magnetic resonance imaging findings of widespread hepatocellular carcinoma lesions complicated with portal vein thrombosis.
PubMedID- 21443089 Chemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis.
PubMedID- 21054520 Background and aim: we aimed to validate the non-invasive criteria for the characterization of portal vein thrombosis (pvt) in patients with cirrhosis and hepatocellular carcinoma (hcc).
PubMedID- 21033233 The efficacy of combined transarterial chemoembolization and 3-dimensional conformal radiotherapy for hepatocellular carcinoma with main portal vein thrombosis.
PubMedID- 25584161 Transarterial chemoembolization in unresectable hepatocellular carcinoma with portal vein thrombosis: a perspective on survival.
PubMedID- 22206054 Atypical enhancement pattern of hepatocellular carcinoma with portal vein thrombosis on multiphasic ct.
PubMedID- 25834310 Management of hepatocellular carcinoma with portal vein thrombosis.
PubMedID- 26133576 Introduction: this study compares radioembolization ((90)y) versus doxorubicin drug eluting beads (debdox) in the treatment of unresectable hepatocellular carcinoma with portal vein thrombosis.
PubMedID- 23914915 Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib.
PubMedID- 21190093 Introduction: portal vein thrombosis is frequently associated with hepatocellular carcinoma (hcc).
PubMedID- 21659784 Long-term outcome of combined interferon-alpha and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis.
PubMedID- 25847227 Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
PubMedID- 21076591 Conclusion: this simplified method demonstrates excellent technical feasibility, an acceptable range of complications, and is hence recommended for the management of advanced hepatocellular carcinoma with portal vein thrombosis.
PubMedID- 20981227 Treatment of hepatocellular carcinoma with portal vein thrombosis by sorafenib combined with hepatic arterial infusion chemotherapy.
PubMedID- 25502254 Eus-fna of a portal vein thrombosis in a patient with a hidden hepatocellular carcinoma: confirmation technique after contrast-enhanced ultrasound.
PubMedID- 21224554 We herein report a case of advanced hepatocellular carcinoma (hcc) with vp4 portal vein thrombosis (pvtt).
PubMedID- 22330617 Surgical approach to multifocal hepatocellular carcinoma with portal vein thrombosis and arterioportal shunt leading to portal hypertension and bleeding: a case report.
PubMedID- 25088384 Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis.
PubMedID- 26157747 New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis.

Page: 1